1-3 of 3
Leonidas Platanias, MD PhD
Close
Sort by
Journal Articles

Efficacy of Dual Inhibition of p38 Mitogen Activated Protein Kinase (MAPK) and Tie-2 Kinase in Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)

Lohith Shakaladevanapura Bachegowda, MDMRCP(UK), Ioannis Mantzaris, MD, Kerry A. Morrone, MD, Nandini Keshkar, Weijuan Li, MD PhD, George Nwankwo, Samira Shahnaz, MD, Tushar D. Bhagat, PhD, Orsolya Giricz, PhD, Sanchari Bhattacharrya, PhD, Yiting Yu, PhD, Carolina D. Schinke, MD, Aby Pynadath, MD, Andrea Pellagatti, PhD, Jacqueline Boultwood, PhD, Michael J Humphries, PhD, Shannon L Winski, PhD, Matthias Bartenstein, MD, Chandan Guha, MD PhD, Leonidas Platanias, MD PhD, Ulrich Steidl, MD PhD, Amit Verma, MD
Journal: Blood
Blood (2014) 124 (21): 4628.
https://doi.org/10.1182/blood.V124.21.4628.4628
Published: 2014
Journal Articles

Activation of TAO2 Kinase by Arsenic Trioxide in Leukemic Cells

Jennifer L. McNeer, MD, Blazej Dolniak, PhD, Barbara Kroczynska, PhD, Antonella Sassano, PhD, Leonidas Platanias, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 5324.
https://doi.org/10.1182/blood.V112.11.5324.5324
Published: 2008
Journal Articles

ICSBP Haplo-Insufficiency Synergizes with SHP2-Activation for Apoptosis Resistance and Cytokine Hypersensitivity in Myeloid Progenitors.

Iwona Konieczna, BA, Elizabeth Horvath, MS, Hao Wang, PhD, Leonidas Platanias, MD, PhD, Elizabeth Eklund, MD
Journal: Blood
Blood (2007) 110 (11): 2209.
https://doi.org/10.1182/blood.V110.11.2209.2209
Published: 2007